[go: up one dir, main page]

Rabaud et al., 1986 - Google Patents

Soluble fibrinogen derivatives generated by thrombin: Affinity for elastik

Rabaud et al., 1986

Document ID
10568452571134085772
Author
Rabaud M
Lefebvre F
Piquet Y
Belloc F
Chevaleyre J
Roudaut M
Bricaud H
Publication year
Publication venue
Thrombosis research

External Links

Snippet

When human citrated plasma is dialysed against a phosphate buffer containing Ca++. citrate anions are removed, thrombin is generated and soluble fibrinogen derivatives (fibrin monomers and/or soluble fibrin polymers) are formed. These derivatives are able to …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Similar Documents

Publication Publication Date Title
Koopman et al. Molecular basis for fibrinogen Dusart (A alpha 554 Arg--> Cys) and its association with abnormal fibrin polymerization and thrombophilia.
US4666884A (en) Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
US5407671A (en) One-component tissue adhesive and a process for the production thereof
US5589462A (en) Method of preparing a biological adhesive enriched with platelet factors, and application
US5290918A (en) Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
AU678439B2 (en) Process for the obtention of a biological adhesive comprising fibrinogen, factor XIII and fibronectin
US5763411A (en) Nondynamic fibrin monomer on bandages, sutures, prostheses and dressings
FR2510408A1 (en) FABRIC GLUE
IE852323L (en) Blood coagulation inhibiting proteins
Dosekun et al. Ancrod in systemic lupus erythematosus with thrombosis: clinical and fibrinolysis effects
JP2001525373A (en) Fibrinolysis inhibitors for sealants
Rabaud et al. Soluble fibrinogen derivatives generated by thrombin: Affinity for elastik
Mohammed et al. Multiple active forms of thrombin: binding to platelets and effects on platelet function.
Bennett et al. The normal coagulation mechanism
US6268483B1 (en) Compositions useful as fibrin sealants
US6613324B1 (en) Adhesive for the gluing of biological tissues
Eritsland et al. Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease
McNicol Disordered fibrinolytic activity and its control
FR2598423A1 (en) ELASTIN-BASED PRODUCT, PROCESS FOR PREPARATION THEREOF AND BIOLOGICAL APPLICATIONS THEREOF, IN PARTICULAR AS BIOMATERIALS AND ARTIFICIAL CARRIERS
Alexander et al. Action of water-insoluble trypsin derivatives on fibrinogen clottability
McDonagh et al. How does hyperfibrinogenemia lead to thrombosis?
Sasajima et al. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system
YAMAGUCHI et al. Fibrinogen Kumamoto with an Aα Arg-19 to Gly substitution has reduced affinity for thrombin possible relevance to thrombosis
Blaskó et al. Decreased heparin sensitivity of cyclohexanedione-modified factor Xa
Weerasinghe et al. Inhibition of the cerebroside sulphate (sulphatide)-induced contact activation reactions by platelet factor four